-
Thrombolysis, thrombectomy or combination, how to choose the treatment of large-vessel occlusive ischemic stroke
Time of Update: 2022-11-05
In order to further enhance the public's understanding of stroke, "Medical Neurology Channel" and "Shanghai Changhai Hospital" held this event, and this article invited Professor Yang Pengfei from Shanghai Changhai Hospital to answer our questions about large-vessel occlusive ischemic stroke (AIS-LVO).
-
The infected person shows symptoms and the nucleic acid is still negative
Time of Update: 2022-05-24
On May 4, at a press conference on the prevention and control of the new coronavirus pneumonia in Beijing, Pang Xinghuo, deputy director of the Beijing Center for Disease Control and Prevention and a
-
Announcement of the General Administration of Market Supervision on the Unqualified Situation of the Sampling Inspection of 7 Batches of Food (No. 38 of 2021
Time of Update: 2021-09-29
For unqualified foods found in random inspections, the State Administration of Market Supervision has instructed provincial market regulatory authorities such as Liaoning, Heilongjiang, Shanghai, Jiangxi, and Shandong to immediately organize verification and disposal, find out the flow of products, and urge enterprises to take measures such as removing unqualified products from shelves and recalling them.
-
BASF seed treatment product Teraxxa (Bromworm fluorobenzene diamide) was approved in the United States
Time of Update: 2021-01-30
"Recently, BASF seed processing product Teraxxa TM was approved by the U.S. Environmental Protection Agency for providing grain growers with a powerful new seed treatment technology to prevent and control the worm, which will be available during the 2021 growth season," WCN Chinese reported.
-
Two pneumonia vaccines from Mercedon and Pfizer are in short supply in the European market
Time of Update: 2020-11-12
' Pneumovax 23 and Pfizer's Prevnar 13 face shortages in the European market as researchers try to use two pneumococcal vaccines as a preventive measure against COVID-19, Reuters reported.
-
Shanxi and Chinese bio-joint research and development center for vaccines
Time of Update: 2020-07-18
Pharmaceutical Network, June 30, the evening of June 28, Shanxi Provincial People's Government and China Biotechnology Co., Ltd (hereinafter referred to as "China Biology") signed a framework agreem
-
Novartis Ligelizumab (QGE031) treats Patients with CSU with higher remission rates
Time of Update: 2020-06-08
CSU is a severe skin disease with unpredictable seizures, symptoms including spontaneous swelling and itching of the skin Novartis (http:// announced that the company's development of anti-IgE h
